Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Interest Coverage Ratio: 2010-2025

Historic Interest Coverage Ratio for Ligand Pharmaceuticals (LGND) over the last 16 years, with Sep 2025 value amounting to 60.36.

  • Ligand Pharmaceuticals' Interest Coverage Ratio rose 1323.15% to 60.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 4.60, marking a year-over-year increase of 164.20%. This contributed to the annual value of -7.44 for FY2024, which is 140.89% down from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 60.36 for Q3 2025, which was up 724.25% from 7.32 recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Interest Coverage Ratio ranged from a high of 3,078.00 in Q3 2023 and a low of -83.75 during Q4 2022.
  • For the 3-year period, Ligand Pharmaceuticals' Interest Coverage Ratio averaged around 284.54, with its median value being 4.24 (2024).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first slumped by 1,092.11% in 2022, then skyrocketed by 8,180.50% in 2023.
  • Quarterly analysis of 5 years shows Ligand Pharmaceuticals' Interest Coverage Ratio stood at 8.44 in 2021, then slumped by 1,092.11% to -83.75 in 2022, then soared by 69.39% to -25.63 in 2023, then soared by 57.42% to -10.91 in 2024, then surged by 1,323.15% to 60.36 in 2025.
  • Its Interest Coverage Ratio stands at 60.36 for Q3 2025, versus 7.32 for Q2 2025 and -41.77 for Q1 2025.